Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases

Can Cui1, Fei Yang2,3, Qian Li2,4,5

  • 1School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Insights

Glutathione peroxidase 4 (GPX4), a key regulator of ferroptosis, can be targeted through its post-translational modifications (PTMs) for disease treatment. Understanding GPX4 PTMs offers new therapeutic strategies for ferroptosis-related conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Biology

Background:

  • Glutathione peroxidase 4 (GPX4) is a critical antioxidant enzyme and the primary regulator of ferroptosis.
  • GPX4's role in cancer, cardiovascular, and neuroscience research has garnered significant attention.
  • Regulation of GPX4 activity is a key area of therapeutic interest.

Purpose of the Study:

  • To summarize GPX4 protein characteristics, enzyme properties, and post-translational modifications (PTMs).
  • To explore the potential of targeting GPX4 PTMs for treating ferroptosis-related diseases.

Main Methods:

  • Review of existing literature on GPX4 regulation, including transcriptional control and PTMs.
  • Analysis of how PTMs like ubiquitination, succination, phosphorylation, and glycosylation impact GPX4 function.
  • Synthesis of information to propose therapeutic strategies targeting GPX4 PTMs.

Main Results:

  • GPX4 protein levels are regulated by transcription factors SP2 and Nrf2.
  • GPX4 activity can be modulated by selenium/glutathione supplementation or ferroptosis inducers (ML162, RSL3).
  • GPX4 undergoes various PTMs (ubiquitination, succination, phosphorylation, glycosylation) that influence its activity and stability.

Conclusions:

  • GPX4 PTMs represent a novel and promising therapeutic avenue for ferroptosis-related diseases.
  • Targeting GPX4 PTMs could offer new treatment strategies, particularly for cancer.
  • Further research into GPX4 PTMs is warranted to develop effective therapies.

Related Concept Videos

Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
3.7K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.7K